Tonix Pharmaceuticals Holding Corp.
TNXP
$13.44
$0.201.51%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -46.55% | -13.22% | -68.00% | 23.88% | -55.55% |
| Total Depreciation and Amortization | 5.86% | -4.55% | -2.03% | -0.60% | -50.89% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -67.50% | 168.73% |
| Total Other Non-Cash Items | -47.00% | -61.17% | 86.28% | 712.57% | -72.23% |
| Change in Net Operating Assets | 814.29% | -91.69% | 325.96% | -151.15% | 196.85% |
| Cash from Operations | -37.76% | -94.04% | 10.53% | -13.32% | 22.18% |
| Capital Expenditure | -94.80% | -82.54% | -8,683.33% | -100.00% | 66.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Investing | -6.13% | 62.11% | -42,216.67% | -100.00% | 66.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -1,268.79% | 0.00% |
| Issuance of Common Stock | -28.51% | 580.39% | -77.70% | -27.65% | 94.46% |
| Repurchase of Common Stock | -- | 100.00% | 4.76% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -0.23% | -514.58% | 78.55% | 31.13% | -47.27% |
| Cash from Financing | -37.65% | 762.92% | -77.81% | -41.83% | 98.47% |
| Foreign Exchange rate Adjustments | -250.00% | 0.00% | 55.56% | -137.50% | 241.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -71.65% | 1,120.10% | -119.38% | -53.31% | 192.99% |